Skip to main content

Want a detailed portfolio tracker?

CervoMed (CRVO) P/E (2016 - 2026)

CervoMed (CRVO) P/E from Jan 4, 2016 to Jul 21, 2026. The TTM CervoMed (CRVO) P/E is -0.89. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of CervoMed (CRVO)

YearP/EChange
2026-0.89-66.77%
2025-2.68+117.44%
2024-1.23-118.66%
20236.61-937.39%
2022-0.79-38.86%
2021-1.29-66.23%
2020-3.82+99.06%
2019-1.92-64.97%
2018-5.48-53.58%
2017-11.80-4.15%
2016-12.31N/A

Comparison CervoMed (CRVO) P/E with competitors

CervoMed (CRVO) P/E is -0.89.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.19%
NBYStablecoin Development Corp0.00-100.48%
ENLVEnlivex Ltd0.07-108.40%
FGENFibroGen Inc0.24-126.96%
CHRSCoherus Biosciences Inc0.85-195.30%
FBIOFortress Biotech Inc0.95-206.59%
ORMPOramed Pharmaceuticals Inc1.50-268.82%
AGENAgenus Inc3.01-438.03%
INVAInnoviva Inc3.15-454.25%
VXRTVaxart Inc3.55-498.69%
CRMDCorMedix Inc3.63-507.53%
CVACCureVac N.V.4.45-599.32%
GLPGGalapagos NV4.86-645.73%
SRPTSarepta Therapeutics Inc4.88-648.34%
ABEOAbeona Therapeutics Inc5.39-705.10%
ABUSArbutus Biopharma Corp5.60-728.48%
ZVRAZevra Therapeutics Inc5.89-761.23%
SPROSpero Therapeutics Inc6.23-799.55%
CGENCompugen Ltd6.31-809.16%
RIGLRigel Pharmaceuticals6.87-871.84%
SLXNSilexion Therapeutics Corp7.30-919.47%
OMEROmeros Corporation9.26-1139.91%
AUPHAurinia Pharmaceuticals Inc9.58-1176.54%
PLXProtalix BioTherapeutics Inc10.89-1323.24%
ACADAcadia Pharmaceuticals Inc11.73-1417.30%
TBPHTheravance Biopharma Inc12.26-1477.24%
ADMAAdma Biologics Inc12.42-1494.76%
HRMYHarmony Biosciences Holdings Inc13.82-1652.23%
SABSSAB Biotherapeutics Inc14.14-1687.73%
NAGENiagen Bioscience Inc14.82-1764.32%
INCYIncyte Corp15.82-1877.13%
REGNRegeneron Pharmaceuticals Inc15.86-1880.96%
PBYIPuma Biotechnology Inc17.32-2044.84%
CPRXCatalyst Pharmaceuticals Inc17.44-2058.72%
EXELExelixis Inc17.54-2069.81%
TGTXTG Therapeutics Inc18.97-2230.20%
MDXGMimedx Group Inc20.55-2408.38%
XOMAXOMA Royalty Corp22.87-2669.27%
ARGXArgen X SE24.30-2829.14%
CTMXCytomX Therapeutics Inc24.82-2887.89%
XOMAOXOMA Royalty Corp25.34-2946.71%
HALOHalozyme Therapeutics Inc25.62-2978.04%
XOMAPXOMA Royalty Corp25.67-2983.25%
VRTXVertex Pharmaceuticals Inc27.99-3244.35%
RPRXRoyalty Pharma plc - Class A28.69-3322.17%
SLNOSoleno Therapeutics Inc29.02-3358.98%
ASNDAscendis Pharma A/S30.09-3479.19%
LGNDLigand Pharmaceuticals Inc - Class B37.91-4358.25%
APLSApellis Pharmaceuticals Inc39.02-4482.84%
BMRNBiomarin Pharmaceutical Inc42.21-4841.21%
KRYSKrystal Biotech Inc45.34-5192.95%
ONCBeiGene Ltd69.54-7910.74%
PHARPharming Group N.V.75.03-8526.83%
TECHBio-Techne Corp101.96-11551.90%
VCELVericel Corp109.92-12446.30%
ALNYAlnylam Pharmaceuticals Inc117.96-13349.77%
GMABGenmab140.29-15857.38%
TLXTelix Pharmaceuticals Ltd162.15-18312.91%
CORTCorcept Therapeutics Inc212.86-24008.03%